Long-term follow-up of 78 of 146 children from the IMPACT trial of early-life peanut oral immunotherapy: 80% (32/40) given it with no further treatment were eating peanut 8–11 years later; 35% reported reactions, 5 needing epinephrine.
RCTn = 78
Dantzer et al. Early-life peanut oral immunotherapy associated with long-term ingestion and immunologic changes